pediatric obesity clinical trial design

Semaglutide Improves BMI Category in Phase 3 Pediatric Obesity Trial — Photo by the northern lense on Pexels

7 Hidden Flaws That Derail Pediatric Obesity Clinical Trials

7 Hidden Flaws That Derail Pediatric Obesity Clinical Trials Seven distinct design flaws account for over 60% of failed pediatric obesity trials. The most common errors involve using adult BMI percent reductions, skipping growth-plate monitoring, neglecting dual consent, limiting follow-up, overlooking regulatory nuances, poor statistical planning, and ignoring psychosocial metrics.